Continuous glucose monitoring results in lower HbA

Autor:	S S, Paramasivam, K, Chinna, A K K, Singh, J, Ratnasingam, L, Ibrahim, L L, Lim, A T B, Tan, S P, Chan, P C, Tan, S Z, Omar, R W, Bilous, S R, Vethakkan
Rok vydání:	2018
Předmět:	Adult Blood Glucose Glycated Hemoglobin Diabetes Gestational Pregnancy Blood Glucose Self-Monitoring Malaysia Humans Insulin Female Prenatal Care Standard of Care
Zdroj:	Diabetic medicine : a journal of the British Diabetic AssociationReferences. 35(8)
ISSN:	1464-5491
Popis:	To determine if therapeutic, retrospective continuous glucose monitoring (CGM) improves HbAThis prospective, randomized controlled, open-label trial evaluated 50 women with insulin-treated GDM randomized to either retrospective CGM (6-day sensor) at 28, 32 and 36 weeks' gestation (Group 1, CGM, n = 25) or usual antenatal care without CGM (Group 2, control, n = 25). All women performed seven-point capillary blood glucose (CBG) profiles at least 3 days per week and recorded hypoglycaemic events (symptomatic and asymptomatic CBG 3.5 mmol/l; non-fasting 4.0 mmol/l). HbABaseline characteristics (age, pre-pregnancy BMI, HbACGM use may be beneficial in insulin-treated GDM because it improves HbA
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::a97177e0804395c4f9c58204b0056d85 https://pubmed.ncbi.nlm.nih.gov/29663517 Zobrazit plný text záznamu Plný text